Skip to main content

Soleno Therapeutics Inc

SLNODelisted May 18, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001484565

Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Soleno Therapeutics Inc changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of SLNO: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders3941+2
Shares28.8M50.7M+21.8M (+75.7%)
Value$11.8M$11.2M−$577.5K (−4.9%)

New holders (7)

Institutions that held Soleno Therapeutics Inc at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to SLNO in Q1 2022
InstitutionSharesValue% of portfolio
AIGH Capital Management LLC6,800,000$1.52M0.55%
Worth Venture Partners, LLC1,691,840$377.0K0.18%
Empery Asset Management, LP1,401,400$313.0K1.47%
Commonwealth Equity Services, LLC100,000$22.0K0.00%
Warberg Asset Management LLC27,000$6.00K0.00%
Victory Capital Management Inc13,387$3.00K0.00%
Simplex Trading, LLC156$00.00%

Sold out (5)

Institutions that held Soleno Therapeutics Inc at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of SLNO in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Two Sigma Securities, LLC67,326$28.0K
UBS Group AG30,211$12.0K
Virtu Financial LLC23,628$10.0K
Migdal Insurance & Financial Holdings Ltd.9,873$5.00K
Bank of America Corp107$0